Onyx Pharmaceuticals

Changing the Way Cancer is Treated

• Home
• About Us
  • Overview
  • Historical Timeline
  • Executive Team
  • Board of Directors
  • Corporate Responsibility
  • Corporate Values
  • Awards and Recognitions
  • Contact Us
• Products
  • Overview
  • Nexavar for Kidney Cancer
  • Nexavar for Liver Cancer
  • Patient Access
• Development
  • Overview
  • Clinical Pipeline
  • Sorafenib
  • Carfilzomib
  • ONX 0801
  • ONX 0803 and ONX 0805
  • ONX 0912
  • ONX 0914
  • Cell Cycle Kinase Inhibitor
• Investors
  • Overview
  • Financial Information
  • Stock Information
  • Analyst Coverage
  • Event Calendar
  • Annual Report
  • Proxy Materials
  • SEC Filings
  • Corporate Governance
  • Information Request
• News and Media
  • Overview
  • Press Releases
  • Online Media Kit
• Careers
  • Overview
  • Job Openings
  • Benefits
  • How to Apply
  • Corporate Values

• Home
• About Us
• Products
• Development
• Investors
• News and Media
• Careers